aflatoxin b1 has been researched along with Chronic Hepatitis C in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 3 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Y; Wang, C; Xiao, P; Xu, H; Zhang, Y | 1 |
| Dejean, A; Generalov, MI; Granov, DA; Kalinina, O; Marchio, A; Pineau, P; Rebbani, K; Tarkova, AB; Urbanskii, AI | 1 |
| El-Serag, HB | 1 |
| Cecere, A; Gattoni, A; Marotta, F; Vangieri, B | 1 |
| Changchien, CS; Chen, CH; Chen, PF; Hsu, MC; Hu, TH; Hung, CH; Lee, CM; Lee, SC; Lu, SN; Tung, HD; Wang, JH; Wang, MH | 1 |
| Devesa, SS; Fraumeni, JF; Hsing, AW; McGlynn, KA; Tsao, L | 1 |
3 review(s) available for aflatoxin b1 and Chronic Hepatitis C
| Article | Year |
|---|---|
Hepatocellular carcinoma in the noncirrhotic liver: a literature review.
Topics: Aflatoxin B1; Age Distribution; Alcohol Drinking; beta Catenin; Carcinogenesis; Carcinoma, Hepatocellular; Cyclin-Dependent Kinase Inhibitor p21; DNA Methylation; Environmental Exposure; Food Contamination; Genes, Tumor Suppressor; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Neoplasms; Non-alcoholic Fatty Liver Disease; Oncogene Proteins; Prognosis | 2019 |
Epidemiology of viral hepatitis and hepatocellular carcinoma.
Topics: Aflatoxin B1; Biomarkers; Carcinoma, Hepatocellular; Coinfection; Cost of Illness; DNA, Viral; Epidemiologic Studies; Genotype; Global Health; Hepatitis B e Antigens; Hepatitis B Surface Antigens; Hepatitis B virus; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Incidence; Liver Cirrhosis; Liver Neoplasms; Meta-Analysis as Topic; Prevalence; Risk Assessment; Risk Factors; United States; Virus Replication | 2012 |
The pathogenesis of hepatocellular carcinoma is multifactorial event. Novel immunological treatment in prospect.
Topics: Aflatoxin B1; Animals; Carcinoma, Hepatocellular; Controlled Clinical Trials as Topic; Gene Expression; Genes, p53; Genetic Therapy; Hepatectomy; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Immunotherapy; Immunotherapy, Active; Interferon-alpha; Liver Cirrhosis; Liver Neoplasms; Liver Regeneration; Mice; Mice, Transgenic; Multicenter Studies as Topic; Mutation; Prognosis; Prospective Studies; Randomized Controlled Trials as Topic; Retrospective Studies; T-Lymphocytes, Cytotoxic; Transforming Growth Factor beta | 2004 |
3 other study(ies) available for aflatoxin b1 and Chronic Hepatitis C
| Article | Year |
|---|---|
Somatic changes in primary liver cancer in Russia: a pilot study.
Topics: Adult; Aflatoxin B1; Aged; Aged, 80 and over; Axin Protein; beta Catenin; Carcinoma, Hepatocellular; Cholangiocarcinoma; Chromosomal Instability; Chromosomes, Human, Pair 18; Cohort Studies; Comorbidity; Female; Genes, p53; Genes, ras; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Liver Neoplasms; Loss of Heterozygosity; Male; Middle Aged; Monosomy; NF-E2-Related Factor 2; Pilot Projects; Point Mutation; Proto-Oncogene Proteins B-raf; PTEN Phosphohydrolase; Risk Factors; Russia; Young Adult | 2013 |
Aflatoxin exposure and hepatitis C virus in advanced liver disease in a hepatitis C virus endemic area in Taiwan.
Topics: Aflatoxin B1; Aflatoxins; Aged; Albumins; Chemical and Drug Induced Liver Injury; Data Collection; Disease Progression; Endemic Diseases; Environmental Exposure; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Liver Diseases; Male; Middle Aged; Risk Factors; Taiwan | 2007 |
International trends and patterns of primary liver cancer.
Topics: Aflatoxin B1; Carcinoma, Hepatocellular; Cholangiocarcinoma; Female; Hepatitis C, Chronic; Humans; Incidence; Liver Neoplasms; Male; Registries; Time Factors | 2001 |